188 related articles for article (PubMed ID: 20203097)
21. Plasma levels of pentraxin 3 in patients with spondyloarthritis.
Nisihara R; Skare TL; Zeni JO; Rasera H; Lidani K; Messias-Reason I
Biomarkers; 2018 Feb; 23(1):14-17. PubMed ID: 28043168
[TBL] [Abstract][Full Text] [Related]
22. Systemic pentraxin-3 levels reflect vascular enhancement and progression in Takayasu arteritis.
Tombetti E; Di Chio MC; Sartorelli S; Papa M; Salerno A; Bottazzi B; Bozzolo EP; Greco M; Rovere-Querini P; Baldissera E; Del Maschio A; Mantovani A; De Cobelli F; Sabbadini MG; Manfredi AA
Arthritis Res Ther; 2014 Nov; 16(6):479. PubMed ID: 25394473
[TBL] [Abstract][Full Text] [Related]
23. Pentraxin 3 is associated with disease activity but not atherosclerosis in patients with systemic lupus erythematosus.
Shimada Y; Asanuma YF; Yokota K; Yoshida Y; Kajiyama H; Sato K; Akiyama Y; Mimura T
Mod Rheumatol; 2014 Jan; 24(1):78-85. PubMed ID: 24261762
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value of pentraxin 3 in patients with chronic heart failure.
Kotooka N; Inoue T; Aoki S; Anan M; Komoda H; Node K
Int J Cardiol; 2008 Oct; 130(1):19-22. PubMed ID: 18045709
[TBL] [Abstract][Full Text] [Related]
25. Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction.
Latini R; Maggioni AP; Peri G; Gonzini L; Lucci D; Mocarelli P; Vago L; Pasqualini F; Signorini S; Soldateschi D; Tarli L; Schweiger C; Fresco C; Cecere R; Tognoni G; Mantovani A;
Circulation; 2004 Oct; 110(16):2349-54. PubMed ID: 15477419
[TBL] [Abstract][Full Text] [Related]
26. Incremental effects of serum uric acid levels, autonomic dysfunction, and low-grade inflammation on nocturnal blood pressure in untreated hypertensive patients and normotensive individuals.
Erden M; Kocaman SA; Poyraz F; Topal S; Sahinarslan A; Boyacı B; Cengel A; Yalçın MR
Turk Kardiyol Dern Ars; 2011 Oct; 39(7):531-9. PubMed ID: 21983762
[TBL] [Abstract][Full Text] [Related]
27. Significant elevation of plasma pentraxin 3 in patients with pelvic inflammatory disease.
Chang CC; Wang PH; Su PH; Lin DB; Ying TH; Yang SF; Hsieh YH
Clin Chem Lab Med; 2011 Oct; 49(10):1655-60. PubMed ID: 21679133
[TBL] [Abstract][Full Text] [Related]
28. Pentraxin 3, a new marker for vascular inflammation, predicts adverse clinical outcomes in patients with heart failure.
Suzuki S; Takeishi Y; Niizeki T; Koyama Y; Kitahara T; Sasaki T; Sagara M; Kubota I
Am Heart J; 2008 Jan; 155(1):75-81. PubMed ID: 18082493
[TBL] [Abstract][Full Text] [Related]
29. Plasma levels of pentraxin-3, an inflammatory protein involved in fertility, are reduced in women with polycystic ovary syndrome.
Tosi F; Di Sarra D; Bonin C; Zambotti F; Dall'Alda M; Fiers T; Kaufman JM; Donati M; Franchi M; Zanolin ME; Bonora E; Moghetti P
Eur J Endocrinol; 2014 Mar; 170(3):401-9. PubMed ID: 24347428
[TBL] [Abstract][Full Text] [Related]
30. Pentraxin 3 increases in adult overweight and obese men after weight loss by dietary modification with exercise training.
Zempo-Miyaki A; Kumagai H; Yoshikawa T; Myoenzono K; So R; Otsuki T; Tanaka K; Maeda S
Appl Physiol Nutr Metab; 2019 Feb; 44(2):111-117. PubMed ID: 29990442
[TBL] [Abstract][Full Text] [Related]
31. Plasma pentraxin 3 concentration increases in endurance-trained men.
Miyaki A; Maeda S; Otsuki T; Ajisaka R
Med Sci Sports Exerc; 2011 Jan; 43(1):12-7. PubMed ID: 20508541
[TBL] [Abstract][Full Text] [Related]
32. Calorie restriction modulates inactivity-induced changes in the inflammatory markers C-reactive protein and pentraxin-3.
Bosutti A; Malaponte G; Zanetti M; Castellino P; Heer M; Guarnieri G; Biolo G
J Clin Endocrinol Metab; 2008 Aug; 93(8):3226-9. PubMed ID: 18492758
[TBL] [Abstract][Full Text] [Related]
33. [Pentraxin 3].
Inoue K
Rinsho Byori; 2011 Jul; 59(7):694-701. PubMed ID: 21874796
[TBL] [Abstract][Full Text] [Related]
34. Acute phase reactant, Pentraxin 3, as a novel marker for the diagnosis of rheumatoid arthritis.
Sharma A; Khan R; Gupta N; Sharma A; Zaheer MS; Abbas M; Khan SA
Clin Chim Acta; 2018 May; 480():65-70. PubMed ID: 29408170
[TBL] [Abstract][Full Text] [Related]
35. Pentraxin 3 in the assessment of ventilator-associated pneumonia: an early marker of severity.
Lin Q; Fu F; Shen L; Zhu B
Heart Lung; 2013; 42(2):139-45. PubMed ID: 23273657
[TBL] [Abstract][Full Text] [Related]
36. High plasma level of long Pentraxin 3 is associated with insulin resistance in women with polycystic ovary syndrome.
Aydogdu A; Tasci I; Tapan S; Basaran Y; Aydogan U; Meric C; Sonmez A; Aydogdu S; Akbulut H; Taslipinar A; Uckaya G; Azal O
Gynecol Endocrinol; 2012 Sep; 28(9):722-5. PubMed ID: 22304663
[TBL] [Abstract][Full Text] [Related]
37. Visit-to-visit blood pressure variability in the elderly: associations with cognitive impairment and carotid artery remodeling.
Nagai M; Hoshide S; Nishikawa M; Masahisa S; Kario K
Atherosclerosis; 2014 Mar; 233(1):19-26. PubMed ID: 24529116
[TBL] [Abstract][Full Text] [Related]
38. [The role of long pentraxin 3, a new inflammatory mediator in inflammatory responses].
Okutani D
Nihon Rinsho Meneki Gakkai Kaishi; 2006 Jun; 29(3):107-13. PubMed ID: 16819259
[TBL] [Abstract][Full Text] [Related]
39. The impact of obesity on pentraxin 3 and inflammatory milieu to acute aerobic exercise.
Slusher AL; Mock JT; Whitehurst M; Maharaj A; Huang CJ
Metabolism; 2015 Feb; 64(2):323-9. PubMed ID: 25467846
[TBL] [Abstract][Full Text] [Related]
40. Inverse relationship between the inflammatory marker pentraxin-3, fat body mass, and abdominal obesity in end-stage renal disease.
Miyamoto T; Rashid Qureshi A; Heimbürger O; Bárány P; Carrero K; Sjöberg B; Lindholm B; Stenvinkel P; Carrero JJ
Clin J Am Soc Nephrol; 2011 Dec; 6(12):2785-91. PubMed ID: 22157708
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
